---
figid: PMC3989997__gr1
figtitle: 'Proliferating cell hypothesis: similarities between cancer cells and Plasmodium
  falciparum'
organisms:
- Plasmodium falciparum
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3989997
filename: gr1.jpg
figlink: /pmc/articles/PMC3989997/figure/fig0005/
number: F1
caption: 'Proliferating cell hypothesis: similarities between cancer cells and Plasmodium
  falciparum. Principle end products of glucose consumption (lactate, alanine, pyruvate,
  glycerol-3-phosphate, and glycerol, shown in red boxes) are similar in both cancer
  cells  and asexual intraerythrocytic malaria parasites . A high glycolytic flux
  maintains rate-limiting glycolytic intermediates to support nucleotide (via glucose-6-phosphate
  to 5-phosphoribosyl-α-pyrophosphate) and lipid biosynthesis (via dihydroxyacetone
  phosphate to glycerol-3-phosphate). Metabolic modifications () allow aerobic glycolysis/fermentation
  to proceed rapidly whilst keeping tricarboxylic acid (TCA) flux low. Anapleorotic
  glutaminolysis follows past part of the TCA cycle through the five-carbon α-ketoglutarate
  . Subsequent conversion of oxaloacetate to phosphoenolpyruvate (PEP) by phosphoenolpyruvate
  carboxykinase (PEPCK, EC 4.1.1.49) allows for further synthesis of biosynthetic
  intermediates (e.g., via shikimate pathway  and isoprenoid biosynthesis ). Abbreviations:
  GLUT-1, glucose transporter 1; PfHT1, Plasmodium falciparum hexose transporter 1;
  HK, hexokinase (EC 2.7.1.1); PGI, phosphoglucose isomerase (EC 5.3.1.9); PFK, phosphofructokinase
  (EC 2.7.1.11); G3PDH, glyceraldehyde 3 phosphate dehydrogenase (EC 1.2.1.12); PGK,
  phosphoglycerate kinase (EC 2.7.2.3); PK, pyruvate kinase (EC 2.7.1.40); LDH, lactate
  dehydrogenase (EC 1.1.1.27); PEPCase, phosphoenolpyruvate carboxylase (EC 4.1.1.31);
  PC, pyruvate carboxylase (EC 6.4.1.1); PDH, pyruvate dehydrogenase (EC 1.2.4.1);
  BCKDH, branched chain ketoacid dehydrogenase (EC 1.2.4.4); Suc-CoA, succinyl-CoA.'
papertitle: 'The proliferating cell hypothesis: a metabolic framework for Plasmodium
  growth and development.'
reftext: J. Enrique Salcedo-Sora, et al. Trends Parasitol. 2014 Apr;30(4):170-175.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8371254
figid_alias: PMC3989997__F1
figtype: Figure
redirect_from: /figures/PMC3989997__F1
ndex: 2cfc6288-dea1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3989997__gr1.html
  '@type': Dataset
  description: 'Proliferating cell hypothesis: similarities between cancer cells and
    Plasmodium falciparum. Principle end products of glucose consumption (lactate,
    alanine, pyruvate, glycerol-3-phosphate, and glycerol, shown in red boxes) are
    similar in both cancer cells  and asexual intraerythrocytic malaria parasites
    . A high glycolytic flux maintains rate-limiting glycolytic intermediates to support
    nucleotide (via glucose-6-phosphate to 5-phosphoribosyl-α-pyrophosphate) and lipid
    biosynthesis (via dihydroxyacetone phosphate to glycerol-3-phosphate). Metabolic
    modifications () allow aerobic glycolysis/fermentation to proceed rapidly whilst
    keeping tricarboxylic acid (TCA) flux low. Anapleorotic glutaminolysis follows
    past part of the TCA cycle through the five-carbon α-ketoglutarate . Subsequent
    conversion of oxaloacetate to phosphoenolpyruvate (PEP) by phosphoenolpyruvate
    carboxykinase (PEPCK, EC 4.1.1.49) allows for further synthesis of biosynthetic
    intermediates (e.g., via shikimate pathway  and isoprenoid biosynthesis ). Abbreviations:
    GLUT-1, glucose transporter 1; PfHT1, Plasmodium falciparum hexose transporter
    1; HK, hexokinase (EC 2.7.1.1); PGI, phosphoglucose isomerase (EC 5.3.1.9); PFK,
    phosphofructokinase (EC 2.7.1.11); G3PDH, glyceraldehyde 3 phosphate dehydrogenase
    (EC 1.2.1.12); PGK, phosphoglycerate kinase (EC 2.7.2.3); PK, pyruvate kinase
    (EC 2.7.1.40); LDH, lactate dehydrogenase (EC 1.1.1.27); PEPCase, phosphoenolpyruvate
    carboxylase (EC 4.1.1.31); PC, pyruvate carboxylase (EC 6.4.1.1); PDH, pyruvate
    dehydrogenase (EC 1.2.4.1); BCKDH, branched chain ketoacid dehydrogenase (EC 1.2.4.4);
    Suc-CoA, succinyl-CoA.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FASTK
  - FOXD3-AS1
  - SLC2A1
  - SLC2A3
  - DICER1
  - BGN
  - GPI
  - PGPEP1
  - FUT3
  - ATP8A2
  - PFKL
  - PFKM
  - PFKP
  - PAEP
  - PREP
  - PTPN22
  - HIF1A
  - SETD2
  - ARNT
  - LDHA
  - LDHB
  - LDHC
  - PC
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - PCK2
  - SEMA6A
  - Glut3
  - Glut1
  - as
  - Hk
  - Pgi
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ATPsynbeta
  - Atpalpha
  - Pfk
  - CG15812
  - Ald1
  - Aldh-III
  - Gpdh1
  - Pgk
  - Coop
  - Pep
  - bgcn
  - pk
  - tgo
  - sima
  - Ldh
  - Pc
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - Pepck2
  - Pepck1
  - slow
  - Low
  - levy
  - COX6AL2
---
